Abstract
徐慧文,李东升,徐经武,王学良,门伯媛,郑全庆,刘蓬勃,宋全江,高海燕,庄贵华,王文娟,唐晓红,王科,陶明.国产血源性乙肝疫苗的远期效果评价[J].Chinese journal of Epidemiology,1992,13(6):362-365
国产血源性乙肝疫苗的远期效果评价
Evaluation of Long-term Efficacy on Plasma-derived Hepatitis B Vaccine
Received:August 20, 1990  
DOI:
KeyWord: 乙肝疫苗  保护效价  抗体应答
English Key Word: Hepatitis B vaccine  Protection rate  Anti-HBs
FundProject:
Author NameAffiliation
Xu Huiwen Department of Epidemiology, Xian Medical University 
李东升 Department of Epidemiology, Xian Medical University 
徐经武 Department of Epidemiology, Xian Medical University 
王学良 Department of Epidemiology, Xian Medical University 
门伯媛 Department of Epidemiology, Xian Medical University 
郑全庆 Department of Epidemiology, Xian Medical University 
刘蓬勃 Department of Epidemiology, Xian Medical University 
宋全江 Department of Epidemiology, Xian Medical University 
高海燕 Department of Epidemiology, Xian Medical University 
庄贵华 Department of Epidemiology, Xian Medical University 
王文娟 Department of Epidemiology, Xian Medical University 
唐晓红 Department of Epidemiology, Xian Medical University 
王科 Department of Epidemiology, Xian Medical University 
陶明 Department of Epidemiology, Xian Medical University 
Hits: 1268
Download times: 400
Abstract:
      1986年4月至1990年5月用随机、双盲和有安慰剂对照的严格实验设计,在西安市郊区对265名5~9岁儿童进行国产血源性乙肝疫苗远期效果评价。疫苗组抗体峰值在T12,随后则下降。抗-HBs阳性率下降缓慢,抗-HBs几何均值下降急骤,但与安慰剂组相比均有显著差别。抗-HBs峰值高低及应答时间早晚与随后抗体持续时间长短呈正相关关系。四年观察结果显示疫苗对HBV感染的保护率为80%,如针对HBsAg而言,保护率为100%。
English Abstract:
      From April 1986 to May 1990, 265 pupils aged 5 to 9 years in Xian suburbs were studied to evaluate long-term efficacy of plasma-derived hepatitis B vaccine made in China. Anti-HBs titers in vaccine group reached the highest at twelfth month after the first injection and decreased afterwards. The positive rate of anti-HBs decreased slow, but geometric mean titers of anti-HBs fell sharply. Compared with placebo group, the differencem were all significant. The peak anti-HBs titers and the respons time positively correlated withs the persistence of anti-HBs. 4 years' observation showed that protection rate of hepatitis B vaccine against HBV infection was 80%. Protection rate was 100% if HBsAg was only considered.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close